Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
World Journal of Hepatology · 27.08.2026 · 18 (8)
DOI: 10.4254/wjh.117777 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Hepatology, online erschienen am 27.08.2026. Verfasst von Roberta Forlano und 2 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
In this letter to the editor, we discuss the strengths and weaknesses of the paper from Joseph et al . We take to opportunity to review the clinical importance of screening metabolic dysfunction associated steatotic liver disease patients for significant fibrosis. The use of a first line blood test is crucial for cost and availability, although this may overestimate and underestimate in patients with normal liver enzymes. Liver stiffness as a second line test, decreases the number of false positives, although it may be influenced by operator experience, cost and patients’ body habitus. Future studies are required to explore the application of further technologies in the screening. Nevertheless, for the time being, a 2 tier-system still represents the best option to screen a large number of patients and to optimise resources.
Zitieren
APA
Forlano, R., Castellaneta, N. M., & Suppressa, P. (2026). Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease. World Journal of Hepatology, 18(8). https://doi.org/10.4254/wjh.117777
Vancouver
Forlano R, Castellaneta NM, Suppressa P. Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease. World Journal of Hepatology. 2026;18(8). doi:10.4254/wjh.117777
BibTeX
@article{Forlano2026,
author = {Forlano, Roberta and Castellaneta, Nicola Maurizio and Suppressa, Patrizia},
title = {Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease},
journal = {World Journal of Hepatology},
year = {2026},
volume = {18},
number = {8},
doi = {10.4254/wjh.117777}
}
EUVIMED